CURRENT NEWS

• 30.07.2021
  AbbVie Reports Second-Quarter 2021 Financial Results
• 30.07.2021
  Telix Seneffe Production Facility: Progress Update
• 30.07.2021
  SARS CoV-2 Variants Available for Testing
• 30.07.2021
  Shanghai Nearshore Technology Co., Ltd. Won the Second Prize of Shanghai Science and Technology Award
• 29.07.2021
  Recordati: First Half of 2021 Results Approved, Revenue +1.4%, Ebitda ‐3.4%, Net Income +5.2%. Return to Growth in the Second Quarter
• 29.07.2021
  MGI Australia Demo Lab Opens to Support APAC Customers
• 29.07.2021
  Catalent Biologics Has Been Selected to Conduct Cell Line Development
• 29.07.2021
  Electrophysiology for CNS & Pain Drug Discovery
• 29.07.2021
  Lantheus Announces the First and Only FDA Cleared AI-Enabled PSMA Digital Application, aPROMISE, Strengthening Lantheus' Leadership in Prostate Cancer
• 29.07.2021
  Aptar Reports Second Quarter 2021 Results
• 29.07.2021
  QIAGEN Reports Full Results for Q2 and H1 2021
• 29.07.2021
  Bio-Rad Reports Second-Quarter 2021 Financial Results
• 29.07.2021
  Veracyte Announces Second Quarter 2021 Financial Results
• 29.07.2021
  Avantor Reports Second Quarter 2021 Results
• 29.07.2021
  DURECT Corporation Announces Second Quarter 2021 Financial Results and Update of Programs
• 29.07.2021
  Lantern Pharma Reports Second Quarter 2021 Financial Results and Operational Highlights
• 29.07.2021
  A.Menarini Diagnostics Launches a New Real Time PCR Kit for SARS CoV-2 Detection and Variant Screening, CE Marked
• 29.07.2021
  Median Technologies Appoints Jean-Christophe Montigny as Chief Financial Officer and Member of the Executive Committee
• 29.07.2021
  Clariant Significantly Increased Profitability in the Second Quarter of 2021 on the Back of Double-digit Sales Growth
• 29.07.2021
  I-Mab Announces Authorization of a Renewed Stock Repurchase Program by the Company Up to US$40 Million

Records per page:

Page

Total: 21559 records.